Bio-Rad Laboratories Class A
470 hedge funds and large institutions have $8.69B invested in Bio-Rad Laboratories Class A in 2020 Q2 according to their latest regulatory filings, with 103 funds opening new positions, 161 increasing their positions, 154 reducing their positions, and 37 closing their positions.
178% more first-time investments, than exits
New positions opened: 103 | Existing positions closed: 37
31% more capital invested
Capital invested by funds: $6.62B → $8.69B (+$2.07B)
16% more funds holding
Funds holding: 406 → 470 (+64)
2.41% more ownership
Funds ownership: 76.04% → 78.44% (+2.4%)
9% more call options, than puts
Call options by funds: $11.6M | Put options by funds: $10.6M
5% more repeat investments, than reductions
Existing positions increased: 161 | Existing positions reduced: 154
36% less funds holding in top 10
Funds holding in top 10: 11 → 7 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$130M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$129M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$117M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$114M |
| 5 |
State Street
Boston,
Massachusetts
|
+$106M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$288M |
| 2 |
PC
Pelham Capital
London,
United Kingdom
|
-$64.6M |
| 3 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
-$45.9M |
| 4 |
EIP
Easterly Investment Partners
Beverly,
Massachusetts
|
-$45.5M |
| 5 |
AI
Ariel Investments
Chicago,
Illinois
|
-$38M |
BIO Hedge Fund Activity: Q2 2020 in Review
470 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2020, worth a combined $8.69B — up 31% from $6.62B a quarter earlier.
Buyers outnumbered sellers: 103 funds opened new BIO positions and 37 closed out — a net gain of 66 holders — while 161 added to existing stakes and 154 trimmed.
The largest buyer was GQG Partners, opening a new position worth an estimated $130M. The largest seller was BlackRock, cutting an estimated $288M.
- 470 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2020, up from 406 in Q1 2020.
- Funds reported $8.69B of Bio-Rad Laboratories Class A stock for Q2 2020, up 31% quarter-over-quarter.
- 103 funds opened new Bio-Rad Laboratories Class A positions in Q2 2020 and 37 closed out, a net change of +66 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q2 2020 was GQG Partners, an estimated $130M added.
- The largest Bio-Rad Laboratories Class A seller in Q2 2020 was BlackRock, an estimated $288M sold.
Based on aggregated 13F filings for Q2 2020.